Deepak Rustagi - SS Innovations Senior Resources
| SSII Stock | 5.74 0.27 4.49% |
Executive
Deepak Rustagi is Senior Resources of SS Innovations International
| Address | 405, iLabs Info Technology Centre, Gurugram, India, 122016 |
| Phone | 91 73 3755 3469 |
| Web | https://ssinnovations.com |
SS Innovations Management Efficiency
The company has return on total asset (ROA) of (0.107) % which means that it has lost $0.107 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4342) %, meaning that it created substantial loss on money invested by shareholders. SS Innovations' management efficiency ratios could be used to measure how well SS Innovations manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.47. The current Return On Capital Employed is estimated to decrease to -0.95. As of now, SS Innovations' Total Current Assets are increasing as compared to previous years. The SS Innovations' current Non Currrent Assets Other is estimated to increase to about 3.5 M, while Intangible Assets are projected to decrease to under 23.8 K.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Janet MD | Progyny | N/A | |
| James Hart | Progyny | N/A | |
| Daniel Esq | CONMED | 60 | |
| Melissa Cummings | Progyny | N/A | |
| Dan McFadden | Adapthealth Corp | N/A | |
| John Ferrell | CONMED | 57 | |
| Duncan Wright | Schrodinger | N/A | |
| Paul Davie | Schrodinger | N/A | |
| Brent Lalomia | CONMED | 50 | |
| Dave Ross | Teladoc | N/A | |
| Jeff Ehrhardt | Establishment Labs Holdings | N/A | |
| Christie Archbold | Adapthealth Corp | 51 | |
| Christine Archbold | Adapthealth Corp | 51 | |
| Christopher Joyce | Adapthealth Corp | 60 | |
| Nikolaos Nanis | Teladoc | 49 | |
| Richard II | Adapthealth Corp | 57 | |
| Bijesh Chandran | Procept Biorobotics Corp | N/A | |
| Daniella Mehalik | UFP Technologies | 34 | |
| Anton Hie | Adapthealth Corp | N/A | |
| Adam Vandervoort | Teladoc | 49 | |
| Russell III | Adapthealth Corp | 48 | |
Management Performance
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.11 |
SS Innovations Inter Leadership Team
Elected by the shareholders, the SS Innovations' board of directors comprises two types of representatives: SS Innovations inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SSII. The board's role is to monitor SS Innovations' management team and ensure that shareholders' interests are well served. SS Innovations' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SS Innovations' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sonia Shokeen, Head Affairs | ||
| Naveen Amar, Chief Officer | ||
| Barry Cohen, COO Director | ||
| Srinivasa Reddy, Regulatory Operations | ||
| Karan Gauri, Vice Marketing | ||
| Vishwajyoti MD, Chief Director | ||
| Anup Sethi, Group Officer | ||
| Nikhil Sharma, Head Accounts | ||
| Vaishali Singh, Company Secretary | ||
| Deepak Rustagi, Senior Resources | ||
| Colin Eke, Senior Development | ||
| Sudhir MD, CEO Founder | ||
| Minakshi Late, Global Sales | ||
| Rama Reddy, CTO Asia | ||
| Anil Verma, Head Sales | ||
| Arvind Palaniappan, Interim Officer | ||
| Amit Garg, Manager Accounts |
SSII Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is SS Innovations a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.32) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | 1.17 B | ||||
| Shares Outstanding | 193.62 M | ||||
| Shares Owned By Insiders | 83.00 % | ||||
| Shares Owned By Institutions | 0.21 % | ||||
| Number Of Shares Shorted | 148.09 K | ||||
| Price To Book | 29.35 X |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SS Innovations International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SS Innovations. If investors know SSII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SS Innovations listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.06) | Revenue Per Share | Quarterly Revenue Growth 1.925 | Return On Assets | Return On Equity |
The market value of SS Innovations Inter is measured differently than its book value, which is the value of SSII that is recorded on the company's balance sheet. Investors also form their own opinion of SS Innovations' value that differs from its market value or its book value, called intrinsic value, which is SS Innovations' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SS Innovations' market value can be influenced by many factors that don't directly affect SS Innovations' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SS Innovations' value and its price as these two are different measures arrived at by different means. Investors typically determine if SS Innovations is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SS Innovations' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.